Supriya Lifesci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
620.25
-4.2 (-0.67%)
BSENSE

Nov 20

BSE+NSE Vol: 1.47 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Aarti Drugs
Morepen Labs.
Innova Captab
IOL Chemicals
Orchid Pharma
SMS Pharma.
Senores Pharma.
Evonile Pharma
Guj. Themis Bio.
Supriya Lifesci.
Zota Health Care
Why is Supriya Lifescience Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.85% and Operating profit at 5.24% over the last 5 years
2
Negative results in Sep 26
  • PAT(Q) At Rs 29.25 cr has Fallen at -41.1% (vs previous 4Q average)
  • NET SALES(Q) At Rs 206.30 cr has Fallen at -5.4% (vs previous 4Q average)
  • PBDIT(Q) Lowest at Rs 45.41 cr.
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Mildly Bullish on 06-Nov-26 and has generated -10.87% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.37% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -19.67% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Supriya Lifesci. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
-19.67%
-0.36
54.21%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.85%
EBIT Growth (5y)
5.24%
EBIT to Interest (avg)
91.73
Debt to EBITDA (avg)
0.14
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.70
Tax Ratio
25.43%
Dividend Payout Ratio
4.28%
Pledged Shares
0
Institutional Holding
11.91%
ROCE (avg)
27.05%
ROE (avg)
16.58%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
28
Industry P/E
40
Price to Book Value
4.03
EV to EBIT
21.55
EV to EBITDA
18.78
EV to Capital Employed
4.21
EV to Sales
5.61
PEG Ratio
NA
Dividend Yield
0.16%
ROCE (Latest)
19.52%
ROE (Latest)
14.29%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NET SALES(9M)

At Rs 672.58 cr has Grown at 27.14%

-12What is not working for the Company
PAT(Q)

At Rs 29.25 cr has Fallen at -41.1% (vs previous 4Q average

NET SALES(Q)

At Rs 206.30 cr has Fallen at -5.4% (vs previous 4Q average

PBDIT(Q)

Lowest at Rs 45.41 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 22.01%

PBT LESS OI(Q)

Lowest at Rs 35.49 cr.

Loading Valuation Snapshot...
Here's what is not working for Supriya Lifesci.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 35.49 cr has Fallen at -44.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 64.29 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 29.25 cr has Fallen at -41.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 49.68 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 206.30 cr has Fallen at -5.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 218.14 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 45.41 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 22.01%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 35.49 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)